CSL Limited (Melbourne, Australia). 2024 revenue ~US$15B. CSL Behring: plasma therapies (Privigen, Hizentra). CSL Seqirus: influenza vaccines. CSL Vifor: iron deficiency. 30K+ employees. One of Australia's largest biotech companies.
12:54:12 AM · Jul 9, 2026